January 26, 2022
Signs of inflammation in the blood reliably predict and identify severe depression in pregnancy, reports a new study.
January 26, 2022
While heart disease remains the #1 cause of death worldwide, experts have noted that diseases of the brain -- especially Alzheimer's disease and dementia -- are substantially increasing, and they are often associated with many of the same risk factors that cause heart disease, including high blood pressure, obesity, diabetes and tobacco use.
January 25, 2022
People who ate a high-fiber diet and didn’t use over-the-counter probiotic supplements lived the longest after immunotherapy for melanoma. The findings, which were confirmed in mouse studies, suggest that microbes in the gut can be modified to improve this type of cancer treatment.
January 25, 2022
Women who received COVID-19 vaccines had a less than one-day increase in the length of their menstrual cycles around the time of their doses. The findings suggest that women may have a slightly longer menstrual cycle after COVID-19 vaccination, but the change is temporary and within the range of normal variation.
COVID-19 vaccines linked to small increase in menstrual cycle length
January 24, 2022
Researchers were able to accurately predict outbreaks of COVID-19 in Connecticut municipalities using anonymous location information from mobile devices, according to a new study. The novel analysis applied in the study could help health officials stem community outbreaks of COVID-19 and allocate testing resources more efficiently, the researchers said.
Researchers use mobile device data to predict COVID-19 outbreaks
January 21, 2022
Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, developed a recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery.
January 20, 2022
The National Institutes of Health is awarding $170 million over five years, pending the availability of funds, to clinics and centers across the country for a new study that will develop algorithms to predict individual responses to food and dietary routines. Nutrition for Precision Health, powered by the All of Us Research Program (NPH), will recruit a diverse pool of 10,000 participants who are part of the NIH’s All of Us Research Program to inform more personalized nutrition recommendations.
January 20, 2022
In this episode of “This Is Purdue,” we’re featuring a Boilermaker whose innovations are changing and saving lives across the world. Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, developed a recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery. Listen in as Professor Low discusses how the drug works, why the team started using this drug on ovarian cancer patients first, and what attracted him to innovation at Purdue University. (Hint: He’s been a Boilermaker since birth!)
January 19, 2022
People interact with machines in countless ways every day. In some cases, they actively control a device, like driving a car or using an app on a smartphone. Sometimes people passively interact with a device, like being imaged by an MRI machine. And sometimes they interact with machines without consent or even knowing about the interaction, like being scanned by a law enforcement facial recognition system.
January 18, 2022
The survival rate of extremely preterm infants born from 2013 through 2018 in a large network of U.S. research centers improved to 78.3%, compared to 76% for infants born in the network from 2008 to 2012, according to researchers funded by the National Institutes of Health. Their study included more than 10,000 infants born at 22 to 28 weeks of pregnancy at 19 centers of the Neonatal Research Network funded by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). It was led by Edward F. Bell, M.D., of the University of Iowa, Iowa City, and appears in the Journal of the American Medical Association.
Survival rate increases for extremely preterm infants in NIH-funded research network
